Blue Sail Medical announced that as of June 28th, its subsidiary Blue Sail Basheng, a controlling shareholder, has received the full investment of RMB 100 million from A2 round strategic investor Daxing Linkong Development Fund. At the same time, the company has implemented a debt-for-equity swap of RMB 800 million in Blue Sail Basheng's debt through its wholly-owned subsidiary, and the registered capital of Blue Sail Basheng has increased to RMB 147.8 million. The shareholding ratio of the company and its wholly-owned subsidiary inBlue Sail Basheng has changed to 82.7586%.
蓝帆医疗：公司及下属全资子公司对蓝帆柏盛的持股比例变更为82.7586%
Blue Sail Medical: The company and its wholly-owned subsidiary have changed their shareholding in Blue Sail Pashin to 82.7586%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.